Last10K.com

American Bio Medica Corp (ABMC) SEC Filing 8-K Material Event for the period ending Thursday, September 29, 2016

American Bio Medica Corp

HISTORY TOOLS
CIK: 1576940 Ticker: ABMC

View differences made from one to another to evaluate American Bio Medica Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Bio Medica Corp.

Continue

Assess how American Bio Medica Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Bio Medica Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2016 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: ABMC
CIK: 896747
Form Type: 8-K Corporate News
Accession Number: 0001144204-16-126745
Submitted to the SEC: Tue Oct 04 2016 3:38:57 PM EST
Accepted by the SEC: Tue Oct 04 2016
Period: Thursday, September 29, 2016
Industry: Pharmaceutical Preparations
Events:
  1. New Agreement
  2. Unregistered Sales

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/abmc/0001144204-16-126745.htm